Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer
Clinical trial NCT00429871 · COMPLETED
Trial details
- NCT number
- NCT00429871
- Sponsor
- Hellenic Oncology Research Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2007-11-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.